TherapeuticsMD (TXMD) Interest & Investment Income (2014 - 2026)

TherapeuticsMD (TXMD) reported Interest & Investment Income of $41000.0 for Q1 2026, up 41.38% on a YoY basis from $29000.0 in Q1 2025, and up 41.38% quarter-over-quarter from $29000.0 in Q1 2025.

TherapeuticsMD (TXMD) Interest & Investment Income (2014 - 2026) Analysis & Trends

TherapeuticsMD has reported Interest & Investment Income for 6 years, with the latest figure at $41000.0 in Q1 2026.

  • For the quarter ending Q1 2026, Interest & Investment Income rose 41.38% year-over-year to $41000.0; the trailing twelve-month figure through Mar 2026 stood at $77699.0 (up 96.4% YoY), and the FY2025 full-year result was $142000.0, up 5.19% from the prior year.
  • Interest & Investment Income for Q1 2026 stood at $41000.0, up from $29000.0 in the prior quarter.
  • The five-year high for Interest & Investment Income was $41000.0 in Q1 2026, with the low at $29000.0 in Q1 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Teva Pharmaceutical Industries 38.77 Bn 35.04 Bn 1.97 Bn -
2 Zoetis 34.11 Bn 32.16 Bn 1.62 Bn -
3 United Therapeutics 23.68 Bn 21.53 Bn 648.10 Mn 41.80 Mn
4 Aurora Cannabis 16.48 Bn 16.40 Bn 33.43 Mn 3.45 Mn
5 Neurocrine Biosciences 16.19 Bn 14.88 Bn 800.70 Mn 28.10 Mn
6 Elanco Animal Health 11.44 Bn 11.01 Bn 785.00 Mn -
7 Alkermes 7.28 Bn 6.77 Bn -116.06 Mn 8.54 Mn
8 Lantheus Holdings 6.48 Bn 5.98 Bn 230.92 Mn 4.97 Mn
9 Hims & Hers Health 6.35 Bn 5.60 Bn 396.79 Mn -
10 TherapeuticsMD 21,990.60 -8.40 Mn - 41,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 41,000.00
Mar 31, 2025 29,000.00
Jun 30, 2017 3,832.00
Mar 31, 2017 3,867.00
Jun 30, 2016 2,863.00
Mar 31, 2016 2,536.00
Dec 31, 2015 2,280.00
Sep 30, 2015 2,760.00
Mar 31, 2015 18,513.00
Dec 31, 2014 9,553.00
Sep 30, 2014 9,364.00